Telemedicine association asks U.S. Congress for permanent reform

By staff writers

July 1, 2020 -- The American Telemedicine Association (ATA) has sent a letter to U.S. lawmakers, requesting they advance permanent telehealth reform.

U.S. Congress expanded access to telehealth services during the COVID-19 pandemic by giving the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) the authority to waive restrictions on Medicare telehealth services.

The temporary change resulted in many people using telemedicine for the first time and shows more may be more inclined to use it in the future, according to the ATA. With these positive results, the ATA has asked Congress to focus reform on numerous priorities, including:

  • Allow the HHS and the CMS to maintain the authority to add or remove eligible telehealth services
  • Remove the geographic and originating site restrictions to ensure that all patients can access care at home and other appropriate locations
  • Ensure federally qualified health centers and rural health clinics can continue to offer telehealth after the pandemic

Many companies and organizations, including Johns Hopkins Health System, the Michael J. Fox Foundation for Parkinson's Research, and the American College of Physicians, signed the letter.

MeMD offers COVID-19 antibody tests via telehealth
Telehealth provider MeMD is making COVID-19 antibody tests available to consumers and businesses in the U.S. through its virtual ordering platform, in...
Telepathology: Part 2 -- Putting plans into action
The COVID-19 crisis is giving a boost to telepathology. Transitioning from reading pathology slides on a microscope to reading them electronically on...
Telepathology: Part 1 -- COVID-19 gives home working a push
Advances in technology, coupled with a regulatory waiver, have given pathologists the option to work remotely, often from the safety of their home-based...
FDA issues COVID-19 digital pathology device guidance
The U.S. Food and Drug Administration (FDA) has issued a guidance document regarding the use of remote digital pathology devices during the COVID-19 crisis.
Ethos launches home lab testing/telehealth service
Ethos Labs has launched a telehealth lab testing service that will allow patients to provide samples taken in their homes.

Copyright © 2020

Last Updated ls 7/1/2020 12:00:48 PM